Indication
Tuberculosis prophylaxis
Tuberculosis prophylaxis refers to the preventive antimicrobial management of individuals harboring latent *Mycobacterium tuberculosis* infection or those at high risk of developing active disease following recent exposure. Read more about Tuberculosis prophylaxis
16 drugs 15 manufacturers
Drugs that treat it
Common Tuberculosis prophylaxis therapies.
ISONIAZID
ISONIAZID
ISONIAZID
ISONIAZID
ISONIAZID
ISONIAZID
BCG VACCINE (TICE STRAIN) (BCG vaccine, live/PF)
ISONIAZID
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonTuberculosis prophylaxis refers to the preventive antimicrobial management of individuals harboring latent *Mycobacterium tuberculosis* infection or those at high risk of developing active disease following recent exposure.
The primary clinical state involves an asymptomatic, non-transmissible infection where viable mycobacteria are sequestered within pulmonary or extrapulmonary granulomas without microbiological or radiological signs of active pathology.
This preventive strategy primarily targets respiratory and systemic pathways across susceptible populations, including close contacts of infectious cases, young children, and immunocompromised hosts such as individuals with HIV or those receiving immunosuppressive therapies.
Its pathophysiologic aim is to eradicate dormant bacilli and prevent reactivation or progression to destructive, transmissible tuberculosis disease.
- cdc.gov
Tuberculosis prophylaxis refers to the preventive antimicrobial management of individuals harboring latent *Mycobacterium tuberculosis* infection or those at high risk of developing active disease following recent exposure The primary clinical state involves an asymptomatic, non-transmissible infection where viable mycobacteria are sequestered within pulmonary or extrapulmonary granulomas without microbiological or radiological signs of active pathology Its pathophysiologic aim is to eradicate d...
- cdc.gov
Tuberculosis prophylaxis refers to the preventive antimicrobial management of individuals harboring latent *Mycobacterium tuberculosis* infection or those at high risk of developing active disease following recent exposure This preventive strategy primarily targets respiratory and systemic pathways across susceptible populations, including close contacts of infectious cases, young children, and immunocompromised hosts such as individuals with HIV or those receiving immunosuppressive therapies
- tbcontrollers.org
This preventive strategy primarily targets respiratory and systemic pathways across susceptible populations, including close contacts of infectious cases, young children, and immunocompromised hosts such as individuals with HIV or those receiving immunosuppressive therapies
Personalize your experience
Follow Tuberculosis prophylaxis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.